Clinical Psychology Program, University of South Florida, Tampa, FL, USA.
Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida Tampa, FL, USA.
J Alzheimers Dis. 2018;62(1):39-60. doi: 10.3233/JAD-170733.
Vascular cognitive impairment and dementia (VCID) is a diagnostic term applied to cognitively impaired individuals with heterogeneous cerebrovascular conditions affecting large and/or small vessels. Individual biomarkers have been identified as instrumental in relating VCID to specific underlying pathologies to better characterize this syndrome. Emerging research to refine panels of biomarkers will increase classification sensitivity and specificity. Refined VCID clustering based on the severity and pathology of vascular injury will permit the development of optimal prevention and treatment strategies. Here, we review recently reported data concerning the diversity of VCID-related pathology and attempts for VCID clustering based on biomarkers obtained from different sets of measurements. We discuss three major sets of biomarkers: 1) neuroimaging biomarkers, 2) neuropsychological performance measures, and 3) biochemical markers in current VCID clustering. Finally, we highlight the effect of blood-brain barrier health on cerebrovascular disease trajectory.
血管性认知障碍和痴呆(VCID)是一个诊断术语,适用于认知障碍患者,这些患者存在影响大血管和/或小血管的异质性脑血管疾病。已经确定了个别生物标志物在将 VCID 与特定潜在病理相关联方面具有重要作用,以便更好地描述这种综合征。对生物标志物进行的新兴研究将提高分类的敏感性和特异性。基于血管损伤的严重程度和病理对 VCID 进行细化聚类将允许制定最佳的预防和治疗策略。在这里,我们回顾了最近关于 VCID 相关病理多样性的报告数据,并根据从不同测量集获得的生物标志物对 VCID 进行聚类的尝试。我们讨论了三大类生物标志物:1)神经影像学生物标志物,2)神经心理学表现测量,以及 3)当前 VCID 聚类中的生化标志物。最后,我们强调了血脑屏障健康对脑血管疾病轨迹的影响。